Biotechnology · Healthcare
CEO, Board Member
2024-01-01–present
Board Member
Inhibrx Biosciences, Inc. (INBX)Equibles does not estimate personal net worth.
Get an email with a short summary when Inhibrx Biosciences, Inc. publishes a filing, an earnings call transcript or a press release.
Get INBX alertsMark P. Lappe is recorded as Board Member at Inhibrx Biosciences, Inc. (INBX) since January 1, 2024 and CEO at Inhibrx Biosciences, Inc. (INBX). The newest filing on record that lists Mark P. Lappe as CEO and Board Member at Inhibrx Biosciences, Inc. (INBX) is dated April 23, 2026. The proxy statement of Inhibrx Biosciences, Inc. reports total compensation of $2,892,473 for Mark P. Lappe in fiscal 2025, including a base salary of $695,250. Disclosed compensation is on record for 3 fiscal years. Inhibrx Biosciences, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Inhibrx Biosciences, Inc. includes Kelly D. Deck (CFO), Douglas G. Forsyth (Board Member), Jon Faiz Kayyem (Board Member) and 2 others.
2024-01-01–present
Last confirmed April 23, 2026
Start not stated–present
Last confirmed April 23, 2026
Biotechnology · Healthcare
CEO, Board Member
2024-01-01–present
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Inhibrx Biosciences, Inc. (INBX) | Chief Executive Officer and Chairman of the Board of Directors | $695,250 | $2,892,473 |
| 2024 | Inhibrx Biosciences, Inc. (INBX) | Chief Executive Officer and Chairman of the Board of Directors | $695,250 | $4,691,783 |
| 2023 | Inhibrx Biosciences, Inc. (INBX) | Chief Executive Officer and Chairman of the Board of Directors | $675,000 | $2,802,021 |
No call appearances or filed executive changes recorded yet.